214 related articles for article (PubMed ID: 34907588)
61. From guaiac to immune fecal occult blood tests: the emergence of technology in colorectal cancer screening.
Greenwald B
Gastroenterol Nurs; 2005; 28(2):90-6. PubMed ID: 15832108
[TBL] [Abstract][Full Text] [Related]
62. Cascade colorectal cancer screening guidelines: a global conceptual model.
Winawer SJ; Krabshuis J; Lambert R; O'Brien M; Fried M;
J Clin Gastroenterol; 2011 Apr; 45(4):297-300. PubMed ID: 21301355
[TBL] [Abstract][Full Text] [Related]
63. Cost Effectiveness of Colorectal Cancer Screening Strategies.
Patel SS; Kilgore ML
Cancer Control; 2015 Apr; 22(2):248-58. PubMed ID: 26068773
[TBL] [Abstract][Full Text] [Related]
64. Colonoscopy and Sigmoidoscopy Use among the Average-Risk Population for Colorectal Cancer: A Systematic Review and Trend Analysis.
Cardoso R; Niedermaier T; Chen C; Hoffmeister M; Brenner H
Cancer Prev Res (Phila); 2019 Sep; 12(9):617-630. PubMed ID: 31289028
[TBL] [Abstract][Full Text] [Related]
65. Colon cancer screening and surveillance controversies.
Lieberman D
Curr Opin Gastroenterol; 2009 Sep; 25(5):422-7. PubMed ID: 19465849
[TBL] [Abstract][Full Text] [Related]
66. Diagnostic accuracy of immunochemical versus guaiac faecal occult blood tests for colorectal cancer screening.
Parra-Blanco A; Gimeno-García AZ; Quintero E; Nicolás D; Moreno SG; Jiménez A; Hernández-Guerra M; Carrillo-Palau M; Eishi Y; López-Bastida J
J Gastroenterol; 2010 Jul; 45(7):703-12. PubMed ID: 20157748
[TBL] [Abstract][Full Text] [Related]
67. Adherence to national guidelines for colorectal cancer screening in Israel: Comprehensive multi-year assessment based on electronic medical records.
Paltiel O; Keidar Tirosh A; Paz Stostky O; Calderon-Margalit R; Cohen AD; Elran E; Valinsky L; Matz E; Krieger M; Yehuda AB; Jaffe DH; Manor O
J Med Screen; 2021 Mar; 28(1):25-33. PubMed ID: 32356670
[TBL] [Abstract][Full Text] [Related]
68. Men with negative results of guaiac-based fecal occult blood test have higher prevalences of colorectal neoplasms than women with positive results.
Brenner H; Hoffmeister M; Birkner B; Stock C
Int J Cancer; 2014 Jun; 134(12):2927-34. PubMed ID: 24374771
[TBL] [Abstract][Full Text] [Related]
69. Impact of screening colonoscopy on outcomes in colorectal cancer.
Matsuda T; Ono A; Kakugawa Y; Matsumoto M; Saito Y
Jpn J Clin Oncol; 2015 Oct; 45(10):900-5. PubMed ID: 26254299
[TBL] [Abstract][Full Text] [Related]
70. Screening for Colorectal Cancer With Fecal Immunochemical Testing With and Without Postpolypectomy Surveillance Colonoscopy: A Cost-Effectiveness Analysis.
Greuter MJE; de Klerk CM; Meijer GA; Dekker E; Coupé VMH
Ann Intern Med; 2017 Oct; 167(8):544-554. PubMed ID: 28973514
[TBL] [Abstract][Full Text] [Related]
71. Longitudinal Adherence to Immunochemical Fecal Occult Blood Testing vs Guaiac-based FOBT in an Organized Colorectal Cancer Screening Program.
Benito L; Travier N; Binefa G; Vidal C; Espinosa J; Milà N; Garcia M
Cancer Prev Res (Phila); 2019 May; 12(5):327-334. PubMed ID: 30890542
[TBL] [Abstract][Full Text] [Related]
72. [Fecal occult blood test for colorectal cancer screening].
Wielandt AM; Hurtado C; Moreno M; Zárate A; López-Köstner F
Rev Med Chil; 2021 Apr; 149(4):580-590. PubMed ID: 34479346
[TBL] [Abstract][Full Text] [Related]
73. Immunochemical testing of individuals positive for guaiac faecal occult blood test in a screening programme for colorectal cancer: an observational study.
Fraser CG; Matthew CM; Mowat NA; Wilson JA; Carey FA; Steele RJ
Lancet Oncol; 2006 Feb; 7(2):127-31. PubMed ID: 16455476
[TBL] [Abstract][Full Text] [Related]
74. Long-Term Effectiveness of Sigmoidoscopy Screening on Colorectal Cancer Incidence and Mortality in Women and Men: A Randomized Trial.
Holme Ø; Løberg M; Kalager M; Bretthauer M; Hernán MA; Aas E; Eide TJ; Skovlund E; Lekven J; Schneede J; Tveit KM; Vatn M; Ursin G; Hoff G;
Ann Intern Med; 2018 Jun; 168(11):775-782. PubMed ID: 29710125
[TBL] [Abstract][Full Text] [Related]
75. Screening for Colorectal Cancer and Evolving Issues for Physicians and Patients: A Review.
Lieberman D; Ladabaum U; Cruz-Correa M; Ginsburg C; Inadomi JM; Kim LS; Giardiello FM; Wender RC
JAMA; 2016 Nov; 316(20):2135-2145. PubMed ID: 27893135
[TBL] [Abstract][Full Text] [Related]
76. Pooled rates of adenoma detection by colonoscopy in asymptomatic average-risk individuals with positive fecal immunochemical test: a systematic review and meta-analysis.
Mohan BP; Khan SR; Daugherty E; Chandan S; Ponnada S; Facciorusso A; Kassab LL; Asokkumar R; Adler DG
Gastrointest Endosc; 2022 Aug; 96(2):208-222.e14. PubMed ID: 35413330
[TBL] [Abstract][Full Text] [Related]
77. Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection.
Hundt S; Haug U; Brenner H
Ann Intern Med; 2009 Feb; 150(3):162-9. PubMed ID: 19189905
[TBL] [Abstract][Full Text] [Related]
78. The use of screening colonoscopy for patients cared for by the Department of Veterans Affairs.
El-Serag HB; Petersen L; Hampel H; Richardson P; Cooper G
Arch Intern Med; 2006 Nov; 166(20):2202-8. PubMed ID: 17101937
[TBL] [Abstract][Full Text] [Related]
79. Estimated Lifetime Gained With Cancer Screening Tests: A Meta-Analysis of Randomized Clinical Trials.
Bretthauer M; Wieszczy P; Løberg M; Kaminski MF; Werner TF; Helsingen LM; Mori Y; Holme Ø; Adami HO; Kalager M
JAMA Intern Med; 2023 Nov; 183(11):1196-1203. PubMed ID: 37639247
[TBL] [Abstract][Full Text] [Related]
80. Colorectal cancer screening: 20 years of development and recent progress.
Zavoral M; Suchanek S; Majek O; Fric P; Minarikova P; Minarik M; Seifert B; Dusek L
World J Gastroenterol; 2014 Apr; 20(14):3825-34. PubMed ID: 24744575
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
